Pharma Market Access Insights - from Petauri Evidence

• Global Pricing and Market Access – Strategies for Success in an Evolving Landscape

  Send us a textUncover the forces driving change in global pricing and accessIn this expert-led discussion we explore the latest trends, challenges, and strategic considerations shaping global pricing and market access (GPMA).At Petauri Evidence, our Global Pricing and Market Access Team are growing to meet the increasing complexity of global launch and access, bringing together fresh perspectives and decades of real-world experience. In this episode, our experts, Clare Foy and Adam Brown, are joined by two new additions to the team, Catherine Beecher and Sam Davies, who bring extensive expertise from both consultancy and industry.Ben Spurr (Head of Partnerships, Petauri Evidence) hosts the panel discussion with Clare, Adam, Catherine, and Sam as they explore the key issues facing Pharmaceutical and Medtech companies as they prepare for global launch, navigate payer expectations, and develop value-driven pricing strategies.This episode was first broadcast as a live webinar. Learn more at: https://petauri.com/insights/webinar-global-pricing-market-access-strategies/Discover our global pricing and market access services at: https://petauri.com/gpma/ To explore your pricing and market access strategy with our experts or to put your question to the panel, email [email protected] to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  52:41

  --------

  52:41
• Transforming Global Market Access: Smarter Resource Management with Local Affiliates

  Send us a textDiscover a smarter way to manage and share market access resources with local affiliatesAre your global market access resources scattered, leading to inconsistencies and confusion among your affiliates? In this webinar we discussed how a centralised platform can streamline resource sharing, ensure access to nationally-relevant evidence, and put the resources your local affiliates need right at their fingertips. The webinar features a conversation with Tim Styche (Market Access & Health Outcomes Director, Smith+Nephew), who shares how his team has solved this challenge with our Global Value Platform.Learn more at: https://petauri.com/insights/transforming-global-market-access-smarter-resource-management-with-local-affiliates-a-live-webinar/To discuss your needs or arrange a full demo of the platform email [email protected]  Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  33:52

  --------

  33:52
• Communicating value to US Payers: Insights for Pharma and Medtech

  Send us a textWhat do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging resonates in the US? How do you prepare for launch in a market as diverse as the US?In this Global Whispers episode, Louise Maddison (Senior Consultant – Global Market Access, Petauri Evidence) interviews some of our colleagues from Petauri Advisors who are either former payers, or former industry market access leads in the US. Louise puts your questions to: - Rory Davies – Vice President of Value and Access, Petauri Advisors, with extensive past experience in Chief Clinical roles at Cigna, Flipt and WellDyne - Dan Vanderpoel – Executive Vice President, Strategic Payer Marketing; Head, Client Solutions, Petauri and former Manager, Trade Relations at Humana - Shana Gunderson Hua – Vice President of Value and Access, Petauri Advisors and former Medical Affairs Executive Director at Genentech and former AVP of Pharmaceutical Strategy and Contracting at Cigna and Express Scripts (now Evernorth)We explore what global market access teams need to know about market access and payer engagement in the US. We  explore how and why value messaging, pricing, and launch strategies are developed differently for the US market, compared to other key launch markets, and what this means for global teams preparing for US launch or taking a US-developed proposition internationally.Learn more at: https://petauri.com/insights/communicating-value-to-us-payers-insights-for-pharma-and-medtech/This episode was first broadcast live as a webinar in March 2025. Learn more about Petauri Evidence: https://petauri.com/petauri-evidence/Learn more about Petauri Advisors: https://petauri.com/petauri-advisors/Meet the ACE team: https://petauri.com/about-us/ace-team/Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  59:02

  --------

  59:02
• Navigating market access: Launch strategies and health economic modelling for medical devices

  Send us a textDiscover how health economics can support successful Medical Device launch, proposition development, and market accessThis episode offers an insightful journey into the world of medical device market access. Specialists from our health economics and market access teams explore the hidden challenges faced by medical devices companies when taking new innovations to healthcare leaders, communicating value and demonstrating evidence, and offer tips on leveraging health economics for a successful launch.Juliet Wallace (Senior Partnerships Coordinator) delves deep with our expert panel into the pivotal role of health economic evaluation in supporting market access for medical devices. Juliet puts audience questions to Hannah Palin (Director, Local Market Access), Calum Jones (Associate Director, Health Economics), and Evelyne Priestman (Consultant, Health Economics).See full details at: https://mtechaccess.co.uk/launch-strategies-health-economic-modelling-medical-devices/This episode was originally broadcast live as webinar in February 2025. https://petauri.com/Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  44:41

  --------

  44:41
• Navigating US payer evidence needs to optimise market access

  Send us a textWhat clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How should evidence be generated, synthesised, and presented for the US market?In this episode, Clare Foy (Director – Global Market Access, Mtech Access) interviews colleagues Nicole Lodowski (Managing Director, Petauri Evidence) and Bob Nordyke (Senior Advisor, Petauri Evidence) about US payer evidence challenges.We explore the evolving evidence needs for US payers. Nicole and Bob share unique perspectives around their extensive experience of driving evidence strategies for US pharmaceutical and medical device launches. Additionally, Nicole and Bob share a ‘sneak peek’ of exclusive insights from a recent Petauri US payer insights survey conducted to better understand the evidence landscape from the US payers’ perspective.They explore:The evolving payer evidence landscape in the USPreferences for clinical and economic evidence by US payersKey differences between the US and other global markets with regard to evidence, HEOR, and market accessOpportunities and challenges when launching new medicines/medical devices/diagnostics in the USInnovative perspectives on evidence planning and strategy for the US marketUS payers’ perspectives, with exclusive insights from Petauri Evidence’s 2024 US payer surveyThis episode was first broadcast as a live webinar in October 2024. Learn more at: https://mtechaccess.co.uk/navigating-us-payer-evidence-needs/Explore more about launching in the US market: https://mtechaccess.co.uk/launching-healthcare-products-in-the-us/Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

  --------  

  57:34

  --------

  57:34

Altri podcast di Economia

Podcast di tendenza in Economia

Su Pharma Market Access Insights - from Petauri Evidence